Skip to main content

Peer Review reports

From: The anti-tumor effect of proteasome inhibitor MG132 for human adenoid cystic carcinoma: correlate with the emerging role of Nrf2/Keap1 signaling pathway

Original Submission
11 Nov 2020 Submitted Original manuscript
30 Aug 2021 Reviewed Reviewer Report - Anthony Francis Markus
2 Sep 2021 Reviewed Reviewer Report - Marius Heitzer
11 Sep 2021 Reviewed Reviewer Report - Sara Deville
3 Dec 2021 Author responded Author comments - Jiazhi Xu
Resubmission - Version 2
3 Dec 2021 Submitted Manuscript version 2
14 Jan 2022 Reviewed Reviewer Report - Marius Heitzer
16 Jan 2022 Reviewed Reviewer Report - Anthony Francis Markus
30 Mar 2022 Author responded Author comments - Jiazhi Xu
Resubmission - Version 3
30 Mar 2022 Submitted Manuscript version 3
4 Apr 2022 Reviewed Reviewer Report - Anthony Francis Markus
6 Apr 2022 Reviewed Reviewer Report - Marius Heitzer
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
13 Apr 2022 Editorially accepted
6 May 2022 Article published 10.1186/s13005-022-00318-1

You can find further information about peer review here.

Back to article page